• FirefoxInstall the new Firefox »
  •  Dow Down 0.06% Nasdaq Up 0.42%

    XOMA Corporation (XOMA)

    -NasdaqGM
    3.83 Down 0.16(4.01%) Feb 26, 4:00PM EST
    Add to Portfolio
    Prev Close:3.99
    Open:3.99
    Bid:3.50 x 200
    Ask:5.84 x 100
    1y Target Est:8.83
    Beta:4.37
    Next Earnings Date:11-Mar-15XOMA Earnings announcement
    Day's Range:3.72 - 3.99
    52wk Range:3.22 - 9.57
    Volume:1,862,699
    Avg Vol (3m):2,808,970
    Market Cap:411.32M
    P/E (ttm):N/A
    EPS (ttm):-1.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    XOMADown 4.01%411.32M
    NVSUp 0.35%247.06B
    REGNDown 0.75%42.78B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):15.84
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.49
    Quarterly EPS Est (Dec-14) :-0.14
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.41

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. Its proprietary products comprise gevokizumab, a humanized allosteric-modulating monoclonal antibody that binds to the inflamma... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback